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Federal Public Health Laws Supporting 
Data Use and Sharing 
The role of health information technology (HIT) in impacting the efficiency and effectiveness of 
healthcare delivery is well-documented.1 As HIT has progressed, the law has changed to allow HIT to 
serve traditional public health functions. This issue brief summarizes federal laws supporting the use and 
sharing of health data within the developing public health HIT landscape. 
Collecting patient data for providing direct healthcare services (commonly called “primary use”) is the 
cornerstone of healthcare practice. In recent years, sharing of electronic patient data for public health 
uses has been given increased attention.2 Health departments and other entities rely on data sharing for 
research and analysis to support disease prevention and health promotion in the population (commonly 
called “secondary use” of data).3 
Law lays the foundation for the recording, storage, and use of electronic health information (EHI). For 
example, law plays a significant role in enabling health departments to use HIT to improve systems that 
individual patient information to track population health trends and interface with similar HIT systems 
used by healthcare providers and facilities. In addition, law supports the sharing of EHI to facilitate 
                                                          
1 See Julia Adler-Milstein, & Ashish K. Jha, Sharing clinical data electronically: A critical challenge for fixing the 
health care system, 307 J. AM. MED. ASS’N  1695 (2012); David Blumenthal & Marilyn Tavenner, The “Meaningful 
Use” Regulation for Electronic Health Records, 363 NEW ENG. J. MED. 6, 501 (2010); Taylor Burke,  The health 
information technology provisions in the American Recovery and Reinvestment Act of 2009: implications for public 
health policy and practice, 125 PUB. HEALTH REPORTS  141 (2010); Neil Calman, et al., Strengthening public health and 
primary care collaboration through electronic health records, 102 AM. J. PUB. HEALTH 13 (2012); Daniel J. Friedman, 
et al., Electronic health records and US public health: current realities and future promise, 103 AM. J. PUB. HEALTH 
1560 (2013); Tiina Maenpaa, et al.,  The utilization rate of the regional health information exchange: how it impacts 
on health care delivery outcomes, 18 J. PUB. HEALTH MGMT. & PRACTICE 215 (2012). 
2 David Blumenthal & Marilyn Tavenner, The “Meaningful Use” Regulation for Electronic Health Records, 363 NEW 
ENG. J. MED. 6, 501 (2010); Sharona Hoffman & Andy Podgurski, Big Bad Data: Law, Public Health, and Biomedical 
Databases, J.L. MED. & ETHICS Suppl. 56 (Spring 2013). 
3 See, e.g., Charles Safran, Meryl Bloomrosen, W. Edward Hammond, et al., Toward a National Framework for the 
Secondary Use of Health Data: An American Medical Informatics Association White Paper, 14 J. AM. MED. 
INFORMATICS ASS’N 1–9 (2007).  
surveillance, emergency and outbreak response, and health communication, among other essential 
public health functions.  
This issue brief summarizes federal laws that have shaped state, tribal, local, and territorial health 
departments’ use of HIT, including  
· Laws that promote healthcare providers’ HIT implementation and use;  
· Laws that address how EHI collected for primary uses can be shared with healthcare providers 
and others for primary and secondary purposes, including public health activities; and 
· Privacy laws that govern the types of EHI that can be disclosed and the permitted uses of EHI. 
Promoting Electronic Health Records to Improve Population Health 
While health information collected for patient care has been used for public health purposes for 
decades, the transition from paper to electronic records has revolutionized the efficiency, capacity, and 
functions of the US health system. The electronic revolution in the healthcare sector spreads into the 
public health sector by improving the overall value of information and the ease of sharing it.
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law has been a driving force in HIT’s implementation and use.5 
Enacted as part of the American Recovery and Reinvestment Act of 2009, the Health Information 
Technology for Economic and Clinical Health (HITECH) Act launched reforms to promote the use of HIT 
by private providers serving Medicare and Medicaid beneficiaries.6 HITECH Act provisions  
· Established the Office of the National Coordinator for Health Information Technology and 
committees that provide standards and specifications for HIT quality;7 
· Required federal agencies to use HIT and provide for its voluntary use by private providers;8 
· Provided for testing, research, grants, and loans for implementation and demonstrations for HIT 
education, including financial assistance to states and tribes;9  
· Applied privacy and security requirements and penalties to HIT and required audits and 
enforcement;10 and 
· Secured incentive payments through the Centers for Medicare and Medicaid Services (CMS) for 
professionals and hospitals that are deemed eligible based on their “meaningful use” of certified 
electronic health record (EHR) technologies.11  
                                                          
4 Tara Ramanathan, et al., The Role of Law in Supporting Secondary Use of Electronic Health Information,  
43 J.L. MED. & ETHICS (forthcoming 2015). 
5 Id. 
 6 42 U.S.C. ch. 156, available at 
www.healthit.gov/sites/default/files/hitech_act_excerpt_from_arra_with_index.pdf. 
7 42 U.S.C. § 300jj-11. 
8 Id. § 17901. 
9 Id. §§ 17911, 17912, 300jj-31-300jj-38). 
10 42 U.S.C. §§ 17921-17953. 
11  Id. § 300jj-31; 42 C.F.R. §§ 492.6, 492.310; EHR incentive programs, CENTERS FOR MEDICARE AND MEDICAID SERVICES, 
www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/index.html (last accessed Dec. 4, 
Regulations set three stages of requirements for professionals and facilities to adopt certified EHR
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technologies and use them for certain purposes, including public health promotion.13   
The Stage 1 meaningful use regulations that became effective in 2012 set standards for data capture, 
use, and sharing that providers must meet for reimbursement.14 The Stage 1 standards support EHR 
format uniformity and thus promote better care coordination and outreach to patients.15 CMS 
guidelines clarify that “meaningful use” includes the goal of improving population health outcomes, thus 
establishing link between HIT in the medical community and public health.   
In addition to the standards relating to patient care, Stage 1 meaningful use regulations include 
standards that can promote secondary uses of health data to support public health activities. For 
example, providers can demonstrate meaningful use by generating reports of patients with a specific 
health condition to foster quality improvement, identify and reduce disparities, support research, and 
facilitate outreach.16 Providers can demonstrate Stage 1 meaningful use by using EHR systems to submit 
data to immunization information systems pursuant to applicable law.17 Stage 1 also allows providers to 
demonstrate meaningful use by using EHR systems to communicate syndromic surveillance data to 
public health departments.18  
For providers who demonstrate Stage 1 standards,19 the Stage 2 regulations introduce new 
requirements for demonstrating meaningful use. As in Stage 1, Stage 2 requirements include standards 
that providers must adopt for incentive payments as well as a menu of standards to give providers some 
flexibility in demonstrating meaningful use.20 Many Stage 1 requirements are incorporated in the Stage 
2 regulations to aid progression between meaningful use stages.21 Stage 2 standards include 
                                                          
2013) (providing Medicaid payments of $63,750 over six years and Medicare payments of $44,000 over five years 
for professionals who adopt certified EHRs by 2016, but a 1–3% graduated penalty for only Medicare payments for 
those physicians who do not by 2015). 
12 This issue brief uses the term electronic health record or EHR to refer to patient record systems operated by 
healthcare providers. In contrast, the term electronic health information or EHI to refers more broadly to digital 
health information that may or may not be stored in EHR systems.  
13 HealthIT.gov, Meaningful Use Criteria and How to Attain Meaningful Use of EHRs, 
http://www.healthit.gov/providers-professionals/how-attain-meaningful-use (last accessed Mar. 4, 2015); Health 
IT.gov, ONC, and CMS EHR Incentive Programs and Certification http://www.healthit.gov/policy-researchers-
implementers/certification-and-ehr-incentives (last accessed Mar. 4, 2015); EHR Incentive Programs supra (laying 
out specific requirements for professionals under Medicare and Medicaid). 
14 42 C.F.R. § 492.6. 
15 HealthIT.gov, supra. 
16 42 C.F.R. §§ 495.6(e)(3), (g)(4). 
17 Id. §§ 495.6(e)(9), (g)(9). 
18 42 C.F.R. § 495.6(e)(10), (g)(10). 
19 See Medicare and Medicaid Programs; Modifications to the Medicare and Medicaid Electronic Health Record 
(EHR) Incentive Program for 2014, 79 Fed. Reg. 171, 52910 (Sept. 4 2014) (providing a timetable illustrating the 
progression of meaningful use stages).  
20 See 42 C.F.R. § 495.6(j-m). 
21 See CMS.gov, Stage 1 vs. Stage 2 Comparison Table for Eligible Professional  www.cms.gov/Regulations-and-
Guidance/Legislation/EHRIncentivePrograms/Downloads/Stage1vsStage2CompTablesforEP.pdf (last accessed Dec. 
29, 2014). 
requirements for clinical care and interoperability for EHRs, including Health Information Exchanges 
(HIE), electronic prescribing, transmission of records across settings, and increased patient control.
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Like Stage 1, Stage 2 includes standards that promote public health activities, including laboratory 
reporting, reporting to immunization information systems, reporting to cancer registries and other 
specialized registries, submitting syndromic surveillance data, and identifying patients with specific 
conditions.23 
 Stage 3, projected to take effect in 2017, seeks to improve quality, safety, efficiency, and health 
outcomes, emphasizing population health improvement.24 
Encouraging Electronic Data Use and Sharing with Stakeholders  
In addition to encouraging provider adoption of EHR’s, HITECH’s incentives encourage sharing health 
information with stakeholders, such as electronic reporting of laboratory results and syndromic 
surveillance data to public health departments, reporting vaccinations to immunization information 
systems, and sending healthcare quality data to CMS.25 However, electronic sharing of EHI depends on 
the existence of a functioning technological infrastructure, interoperability of separate HIT systems, and, 
often, presence of organizations that facilitate information sharing between entities. 
EHI sharing, broadly the “secure health data exchange between two or more authorized and consenting 
trading partners,”26 is not possible without a technical infrastructure for the consenting trading partners 
to communicate. HITECH’s incentive payments, which promote the “adoption and meaningful use of 
certified electronic health record (EHR) technology” by healthcare providers, also incentivize 
infrastructure development for EHI sharing by increasing the pervasiveness of HIT systems.27 Moreover, 
providers may cite sharing EHI as a meaningful use of EHR systems to get HITECH incentive payments.28  
HITECH also facilitates EHI sharing by giving the Office of the National Coordinator for Health 
Information Technology (ONC) the authority to endorse technical standards.29 Electronic sharing of 
health information requires that EHR systems are interoperable, or capable of communicating with each 
other. Without set standards, EHR vendors might develop systems that are not interoperable. Because 
HITECH authorizes ONC to review and endorse technical standards for EHR systems, ONC can guide 
different EHR vendors on how to develop interoperable systems.    
                                                          
22 Health Information Technology: Standards, Implementation Specifications, and Certification Criteria for 
Electronic Health Record Technology, 77 Fed. Reg. 171, 54163 (Sept. 4, 2012). 
23 42 C.F.R. § 495.6(j-m). 
24 79 Fed. Reg. 171, 52910. 
25 42 C.F.R. § 495.6. 
26 HiMSS, HIE and Meaningful Use Stage 2 Matrix, available at 
http://www.himss.org/files/HIMSSorg/content/files/MU2_HIE_Matrix_FINAL.pdf (Dec. 2012) (last accessed Dec. 3, 
2014). 
27 42 C.F.R. § 495.2 (a). 
28 NORC, Evaluation of the State Health Information Exchange Cooperative Agreement Program, 
http://www.healthit.gov/sites/default/files/casestudysynthesisdocument_2-8-13.pdf (last accessed Dec. 4, 2014). 
29 42 U.S.C.A. § 300jj-11 (2014). 
In addition, ONC developed the State HIE Cooperative Agreement Program, which allocates funds to 
encourage states to facilitate health information sharing. EHI may be shared through a formalized 
system such as an HIE or a Health Information Organization (HIO), which can vary in structure, 
organization, function, and scope based on implementation. Health information sharing receives broad 
support from states, private entities such as EHR vendors, and the public. Ultimately, promoting health 
information sharing allows for consolidation of disparate data and communication of health status and 
risks for both primary and secondary uses. 
Protecting Privacy and Ensuring Data Security 
The ease with which electronic information can be created and shared highlights the need for the 
privacy and security of sensitive EHI. Federal laws set the foundation for sharing data from patients’ 
EHRs. Most discussed in the literature are the privacy and security provisions that control the access, 
use, and disclosure of individually identifiable health information in the Health Insurance Portability and 
Accountability Act (HIPAA) Privacy Rule.
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The rules implementing HIPAA define protections for health data acquired for primary uses. The general 
rule under HIPAA is that patient authorization is required before data are used by or disclosed to other 
entities.31 In addition to the protection against use and disclosure, HIPAA allows patients to view their 
health information and request copies.32 While HIPAA limits the use and disclosure of health 
information, it also permits certain secondary use exceptions for public health purposes.  
HIPAA provides certain circumstances under which patient data can be disclosed to health departments 
without patient authorization. Under HIPAA, providers may disclose identifiable patient data (protected 
health information or PHI) if required by law, allowing states to pass legal exceptions to HIPAA 
restrictions.33 Providers may also disclose PHI to health departments without patient authorization for 
public health activities, such as communicable disease reporting, or to a public health authority to 
prevent or control disease, injury, or disability under the public health exemption.34   
A covered entity may access, use, and disclose PHI for clinical research without an individual’s 
authorization if 1) it obtains documentation of waiver of individual’s authorization by an institutional 
                                                          
30 Health Insurance Portability and Accountability Act of 1996, Pub. L. No. 104-191, 110 Stat. 1936 (codified as 
amended in scattered sections of 18 U.S.C., 26 U.S.C., and 42 U.S.C.); 45 C.F.R. Parts 160 and 164 (Subparts A and 
E) (2013); Deven McGraw & Alice Leiter, A Policy and Technology Framework for Using Clinical Data to Improve 
Quality, 12 HOUS. J. HEALTH L. & POL’Y 137, 141 (2012). Other federal laws govern the primary and secondary uses of 
specific types of data (see generally Confidentiality of Alcohol and Drug Abuse Patient Records, 42 C.F.R. pt. 2 
(2002); Family Educational Rights & Privacy Act, 20 U.S.C. § 1232g (2013); Privacy Act of 1974, 5 U.S.C. § 552a 
(2010). 
31 45 C.F.R. § 164.508(a)(1). 
32 Id. § 164.502; 45 C.F.R. § 164.524; 45 C.F.R. § 164.528; but see 45 C.F.R. § 164.512. 
33 45 C.F.R. § 164.512(a) (2013). 
34 Id. § 164.512(b) (2013).  
review board or privacy board; 2) the PHI is necessary for this research; or 3) the research is using PHI of 
decedents.
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Providers may disclose EHI without patient authorization when the data have been “de-identified,” 
which usually involves removing 18 types of identification or data aggregation.36 De-identification often 
limits the data’s utility for surveillance of routine clinical data, but still permits re-identification by 
providers or regional health information organizations through randomized patient source codes should 
a public health alert or case report become necessary.37   
Finally, providers may disclose a “limited data set,” including dates and zip codes, without authorization 
and still re-identify patients if they maintain patient codes derived from certain identifiers.38 For other 
ancillary secondary uses, including institutional “learning” related to quality assessment and 
improvement activities, HIPAA permits healthcare entities to access PHI.39 These exemptions and 
permitted uses are central to many existing and future secondary uses of EHI.40 
This issue brief was prepared by Tara Ramanathan, JD, MPH, public health analyst, Cason Schmit, JD, 
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This issue brief includes laws enacted through December 2014. Published March 19, 2015. 
                                                          
35 Id. § 164.512(i) (2013). HIPAA rules separately define clinical research as any investigation or evaluation created 
to develop or enhance generalizable knowledge. 45 C.F.R. § 164.501 (2013). The Common Rule further governs the 
use of PHI by participating departments and agencies researching human subjects (see Federal Policy for the 
Protection of Human Subjects, 45 C.F.R. pt. 46 (2005)) 
36 Data can also be deemed to be de-identified if an expert determines that there is a “very small” risk that data 
could be re-identified. 45 C.F.R. § 164.514(b) (2013). 
37 Standards for Privacy of Individually Identifiable Health Information, 67 Fed. Reg. 157 (Aug. 14, 2001); 45 C.F.R. 
§ 164.514(b). 
38 45 C.F.R. § 164.514(e) (2013); see also Soumitra Sengupta, Neil S. Calman, George Hripcsak, A Model for 
Expanded Public Health Reporting in the Context of HIPAA, 15 J. AM. MED. INFORMATICS ASS’N 5, 569–70 (2008). 
39 45 C.F.R. § 164.501 (2013) (defining health-care uses of PHI); U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES, OCR 
Privacy Brief: Summary of the HIPAA Privacy Rule 4–10 (2003), available at 
http://www.hhs.gov/ocr/privacy/hipaa/understanding/summary/privacysummary.pdf (last accessed Mar. 4, 
2015).  
40 Centers for Disease Control and Prevention, HIPAA Privacy Rule and Public Health: Guidance from CDC and the 
US Department of Health and Human Services, 52 MMWR 1 (Apr. 11, 2003), available at 
http://www.cdc.gov/mmwr/preview/mmwrhtml/m2e411a1.htm (last accessed Mar. 4, 2015). 
